COLLIER ALAN BRIAN (CEO) purchased 0.0% of their position (600.00 shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.50 — a small addition. The strongest form of insider conviction signal.
P · 6 purchases
Filed: 10/3/2019ACC: 0001645470-19-000051
Officer· CEO
Since Jun 2016
+600.00
Net shares
Net buyer
$5.50
Total acquired
6
Open market trades
6B · 0S
6
Total transactions
600.00 acquired
Non-Derivative Transactions6
Common Stock
Direct
Shares
+100.00
Price / share
$0.01
Trade value
$0.84
% of position
0.0%
9/30/2019
25.33M→25.33M
Common Stock
Direct
Shares
+100.00
Price / share
$0.01
Trade value
$0.85
% of position
0.0%
9/30/2019
25.33M→25.33M
Common Stock
Direct
Shares
+100.00
Price / share
$0.01
Trade value
$0.90
% of position
0.0%
9/30/2019
25.33M→25.33M
Common Stock
Direct
Shares
+100.00
Price / share
$0.01
Trade value
$0.95
% of position
0.0%
9/30/2019
25.33M→25.33M
Common Stock
Direct
Shares
+100.00
Price / share
$0.01
Trade value
$0.97
% of position
0.0%
9/30/2019
25.33M→25.33M
Common Stock
Direct
Shares
+100.00
Price / share
$0.01
Trade value
$0.99
% of position
0.0%
9/30/2019
25.33M→25.33M
Total
Net shares
+600.00
Net value
$5.50
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2019 | P · Purchase | +100.00 | $0.01 | $0.84 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 9/30/2019 | P · Purchase | +100.00 | $0.01 | $0.85 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 9/30/2019 | P · Purchase | +100.00 | $0.01 | $0.90 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 9/30/2019 | P · Purchase | +100.00 | $0.01 | $0.95 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 9/30/2019 | P · Purchase | +100.00 | $0.01 | $0.97 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 9/30/2019 | P · Purchase | +100.00 | $0.01 | $0.99 | 0.0% | 25.33M | 25.33M |
| Total | +600.00 | $5.50 | ||||||
Derivative Transactions0
No derivative transactions reported